News

RxSight Warns On FY25 Revenue As Premium Cataract Market Faces Headwinds, Stock Plunges
RxSight, Inc. (NASDAQ:RXST) shares are trading lower premarket on Thursday. On Wednesday, the company disclosed first-quarter ...
Yahoo Finance2d
RxSight, Inc. (RXST)
RxSight projects the sale of 27,579 Light Adjustable Lenses (LAL/LAL+), with a growth of 36%Y/Y increase in procedure volume. Also, the company anticipates the s ALISO VIEJO, Calif., April 02 ...
RxSight Analyst Flags Growth Slowdown As Revised Outlook Misses Expectations
RxSight revised its FY25 revenue outlook below estimates, with Q1 sales lagging expectations. BofA downgraded the stock, citing slowing growth and risks ahead.
Business Insider8d
RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance
April 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device ... driven by: The sale of 27,579 Light Adjustable Lenses (LAL™/LAL+ ®); representing a 36% increase in ...
Yahoo Finance8d
RxSight Warns On FY25 Revenue As Premium Cataract Market Faces Headwinds, Stock Plunges
RxSight projects the sale of 27,579 Light Adjustable Lenses (LAL/LAL+), with a growth of 36%Y/Y increase in procedure volume. Also, the company anticipates the sale of 73 Light Delivery Devices ...
Seeking Alpha8d
RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance
The sale of 27,579 Light Adjustable Lenses (LAL™/LAL+ ®); representing a 36% increase in procedure volume compared to the first quarter of 2024; and The sale of 73 Light Delivery Devices (LDD ...